Get all your news in one place.
100's of premium titles.
One app.
Start reading
StockNews.com
StockNews.com
Business
Riddhima Chakraborty

Is Pfizer a Buy Before New Omicron Boosters Roll Out?

Pfizer Inc. (PFE) discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas.

On August 8, 2022, PFE declared that it would acquire the renowned biopharmaceutical company, Global Blood Therapeutics, Inc. (GBT), under a special agreement, for co-developing advanced treatment and support programs concerning Sickle Cell Disease. This is expected to diversify PFE’s portfolio.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.